Effect of Rutin on Diabetic Auditory Neuropathy in an Experimental Rat Model
- Author:
Aida DOOSTKAM
1
;
Hossein MIRKHANI
;
Kamyar IRAVANI
;
Saied KARBALAY-DOUST
;
Kazem ZAREI
Author Information
- Publication Type:Original Article
- From:Clinical and Experimental Otorhinolaryngology 2021;14(3):259-267
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objectives:. Diabetic auditory neuropathy is a common complication of diabetes mellitus that has a major impact on patients’ quality of life. In this study, we assessed the efficacy of rutin in treating diabetic auditory neuropathy in an experimental rat model.
Methods:. Forty Sprague-Dawley rats were randomly assigned to the following groups: group 1, control; group 2, diabetic rats; and groups 3–5, rats treated with rutin (at doses of 50, 100, and 150 mg/kg, respectively). We used auditory brain stem response, stereology of the spiral ganglion, and measurements of superoxide dismutase (SOD) and malondialdehyde (MDA) to evaluate the effects of treatment.
Results:. Significant improvements in auditory neuropathy were observed in the rutin-treated groups in comparison with the diabetic group (P<0.05). Auditory threshold, wave latency, wave morphology, the volume and number of neurons in the spiral ganglion, and SOD and MDA activity showed improvements following treatment.
Conclusion:. Rutin shows promise as a treatment modality for diabetic auditory neuropathy, but more trials are warranted for its clinical application.
